<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://fn.bmj.com">
<title>Archives of Disease in Childhood - Fetal and Neonatal Edition recent issues</title>
<link>http://fn.bmj.com</link>
<description>Archives of Disease in Childhood - Fetal and Neonatal Edition RSS feed -- recent issues</description>
<prism:eIssn>1468-2052</prism:eIssn>
<prism:publicationName>Archives of Disease in Childhood - Fetal and Neonatal Edition</prism:publicationName>
<prism:issn>1359-2998</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F157?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F158?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F160?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F162?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F167?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F174?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F179?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F182?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F188?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F193?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F199?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F204?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F209?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F211?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F214?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F217?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F219?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F223?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F229?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/97/3/F234?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://hwmaint.fn.bmj.com/misc/home/ADC_95x60.gif" />
</channel>
<image rdf:about="http://hwmaint.fn.bmj.com/misc/home/ADC_95x60.gif">
<title>Archives of Disease in Childhood - Fetal and Neonatal Edition</title>
<url>http://hwmaint.fn.bmj.com/misc/home/ADC_95x60.gif</url>
<link>http://fn.bmj.com</link>
</image>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F157?rss=1">
<title><![CDATA[Highlights from this issue]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F157?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Gestational age and educational outcome</st> <p>A series of papers in this journal and other journals over recent years has highlighted the fact that &lsquo;near-term&rsquo; babies are disadvantaged, compared to &lsquo;term&rsquo; babies, to a degree not previously recognised; Quigley <I>et al</I> have further investigated outcome in terms of subsequent school performance and found that near-term babies do markedly less well than those born at 37+ weeks. They also found that within the gestational age range of 37 up to 42 weeks, babies of 37 and 38 weeks do not do as well as those of 39 to 41 weeks. In the accompanying editorial, Neil Marlow further unpicks the artificial nature of the 1950 WHO definition of &lsquo;Term&rsquo; as &lsquo;37 up to 42 weeks&rsquo;. If you are wondering how it came about that the WHO definition was invented, you should read the 1999 paper by Madar <I>et al</I>.<cross-ref type="bib" refid="R1">1</cross-ref>...]]></description>
<dc:creator><![CDATA[Platt, M. P. W.]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2012-302099</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2012-302099</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Highlights from this issue]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Fantoms</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F157</prism:startingPage>
<prism:endingPage>F157</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F158?rss=1">
<title><![CDATA[Full term; an artificial concept]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F158?rss=1</link>
<description><![CDATA[ <p>Babies born between 37 and 42 weeks of gestation are considered to have been born at the optimal time, and earlier or later delivery is known to be associated with increased risk of a range of outcomes from neonatal complications to impaired outcomes in terms of physical and intellectual ability and even death. Originally, there was an uncertainty about the length of gestation, because the basis for calculating gestational age (from the first day of the last menstrual period) was acknowledged as inaccurate due to conception at different points during the menstrual cycle and variation in an individual woman's cycle, thus a wide definition of full term was developed. With demand-led timing of delivery increasing around the world, many more babies are therefore delivered electively at 37&ndash;38 completed weeks of gestation, despite guidance from a range of official bodies.<cross-ref type="bib" refid="R1">1</cross-ref></p> <p>This rather artificial concept is further cemented in...]]></description>
<dc:creator><![CDATA[Marlow, N.]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301507</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301507</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Pregnancy, Reproductive medicine, Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[Full term; an artificial concept]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Editorials</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F158</prism:startingPage>
<prism:endingPage>F159</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F160?rss=1">
<title><![CDATA[Prevention of preterm births: are we looking in the wrong place? The case for primary prevention]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F160?rss=1</link>
<description><![CDATA[ <sec id="s1"><st>Introduction</st> <p>Preterm birth is the major cause of neonatal and infant mortality in the developed world, being responsible for 55% and 43% of neonatal and infant deaths, respectively, in England and Wales.<cross-ref type="bib" refid="R1">1</cross-ref> With nearly 50 000 preterm births (before 37 weeks gestation) a year in England and Wales (7.6%), the burden is large and research has estimated the annual cost of these babies to be nearly &pound;3 billion<cross-ref type="bib" refid="R2">2</cross-ref> reflecting both initial care costs and ongoing morbidity.</p> <p>To date, both the clinical response and the research agenda have concentrated on two main areas: (1) optimising neonatal care practices and interventions and (2) secondary preventive strategies after preterm birth is threatened or an underlying condition recognised. In terms of neonatal care, there have been major advances in the past 30 years particularly in infants of 32 weeks gestation or less; however, it is unlikely that further...]]></description>
<dc:creator><![CDATA[Rattihalli, R., Smith, L., Field, D.]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301096</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301096</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Obstetrics and gynaecology, Smoking and tobacco, Epidemiologic studies, Drugs: infectious diseases, Drugs: cardiovascular system, Malnutrition, Obesity (nutrition), Contraception, Pregnancy, Reproductive medicine, Child health, Infant health, Neonatal health, Dentistry and oral medicine, Sexual health, Health education, Obesity (public health), Health promotion, Smoking]]></dc:subject>
<dc:title><![CDATA[Prevention of preterm births: are we looking in the wrong place? The case for primary prevention]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Leading articles</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F160</prism:startingPage>
<prism:endingPage>F161</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F162?rss=1">
<title><![CDATA[Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F162?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>Free-radical-induced reperfusion injury has been recognised as an important cause of brain tissue damage after birth asphyxia. Allopurinol reduces the formation of free radicals, thereby potentially limiting the amount of hypoxia&ndash;reperfusion damage. In this study the long-term outcome of neonatal allopurinol treatment after birth asphyxia was examined.</p>
</sec>
<sec><st>Design</st>
<p>Follow-up of 4 to 8 years of two earlier performed randomised controlled trials.</p>
</sec>
<sec><st>Setting</st>
<p>Leiden University Medical Center, University Medical Center Groningen and University Medical Center Utrecht, The Netherlands.</p>
</sec>
<sec><st>Patients</st>
<p>Fifty-four term infants were included when suffering from moderate-to-severe birth asphyxia in two previously performed trials.</p>
</sec>
<sec><st>Intervention</st>
<p>Infants either received 40 mg/kg allopurinol (with an interval of 12 h) starting within 4 h after birth or served as controls.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Children, who survived, were assessed with the Wechsler Preschool and Primary Scales of Intelligence test or Wechsler Intelligence Scale for Children and underwent a neurological examination. The effect of allopurinol on severe adverse outcome (defined as mortality or severe disability at the age of 4&ndash;8 years) was examined in the total group of asphyxiated infants and in a predefined subgroup of moderately asphyxiated infants (based on the amplitude integrated electroencephalogram).</p>
</sec>
<sec><st>Results</st>
<p>The mean age during follow-up (n=23) was 5 years and 5 months (SD 1 year and 2 months). There were no differences in long-term outcome between the allopurinol-treated infants and controls. However, subgroup analysis of the moderately asphyxiated group showed significantly less severe adverse outcome in the allopurinol-treated infants compared with controls (25% vs 65%; RR 0.40, 95%CI 0.17 to 0.94).</p>
</sec>
<sec><st>Conclusions</st>
<p>The reported data may suggest a (neuro)protective effect of neonatal allopurinol treatment in moderately asphyxiated infants.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Kaandorp, J. J., van Bel, F., Veen, S., Derks, J. B., Groenendaal, F., Rijken, M., Roze, E., Venema, M. M. U., Rademaker, C. M., Bos, A. F., Benders, M. J.]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300356</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300356</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Clinical trials (epidemiology), Epidemiologic studies, Editor's choice, Drugs: cardiovascular system, Stroke, Developmental paediatrics, Trauma, Injury]]></dc:subject>
<dc:title><![CDATA[Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F162</prism:startingPage>
<prism:endingPage>F166</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F167?rss=1">
<title><![CDATA[Early term and late preterm birth are associated with poorer school performance at age 5 years: a cohort study]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F167?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To compare school performance at age 5 years in children born at full term (39&ndash;41 weeks gestation) with those born at early term (37&ndash;38 weeks gestation), late preterm (34&ndash;36 weeks gestation), moderately preterm (32&ndash;33 weeks gestation) and very preterm (&lt;32 weeks gestation).</p>
</sec>
<sec><st>Design</st>
<p>Population-based cohort (UK Millennium Cohort Study).</p>
</sec>
<sec><st>Participants</st>
<p>Seven thousand six hundred and fifty children born in 2000&ndash;2001 and attending school in England in 2006.</p>
</sec>
<sec><st>Methods</st>
<p>School performance was measured using the foundation stage profile (FSP), a statutory assessment by teachers at the end of the child's first school year. The FSP comprises 13 assessment scales (scored from 1 to 9). Children who achieve an average of 6 points per scale and at least 6 in certain scales are classified as &lsquo;reaching a good level of overall achievement&rsquo;.</p>
</sec>
<sec><st>Results</st>
<p>Fifty-one per cent of full term children had not reached a good level of overall achievement; this proportion increased with prematurity (55% in early term, 59% in late preterm, 63% in moderately preterm and 66% in very preterm children). Compared with full term children, an elevated risk remained after adjustment, even in early term (adjusted RR 1.05, 95% 1.00 to 1.11) and late preterm children (adjusted RR 1.12, 95% CI 1.04 to 1.22). Similar effects were noted for &lsquo;not working securely&rsquo; in mathematical development, physical development and creative development. The effects of late preterm and early term birth were small in comparison with other risk factors.</p>
</sec>
<sec><st>Conclusions</st>
<p>Late preterm and early term birth are associated with an increased risk of poorer educational achievement at age 5 years.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Quigley, M. A., Poulsen, G., Boyle, E., Wolke, D., Field, D., Alfirevic, Z., Kurinczuk, J. J.]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300888</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300888</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Pregnancy, Developmental paediatrics]]></dc:subject>
<dc:title><![CDATA[Early term and late preterm birth are associated with poorer school performance at age 5 years: a cohort study]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F167</prism:startingPage>
<prism:endingPage>F173</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F174?rss=1">
<title><![CDATA[Neonatal nurse staffing and delivery of clinical care in the SSBC Newborn Network]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F174?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To measure nursing workload and timely completion of essential tasks in relation to the staffing levels recommended by the British Association of Perinatal Medicine (BAPM) in Staffordshire, Shropshire and Black CountryNewborn Network.</p>
</sec>
<sec><st>Methods</st>
<p>A prospective observational study was conducted measuring the time taken by selected nurses to undertake the necessary tasks for babies receiving different levels of care in the Network's six constituent neonatal units. An independent observer was used. The unit and individual's workload was evaluated against BAPM standards. Delays in essential predetermined tasks were recorded. The impact on quantity of care given and on the number of delayed tasks were compared between those with the recommended workload or less and those overstretched.</p>
</sec>
<sec><st>Results</st>
<p>Between October 2008 and February 2009, 89 nurses were observed caring for 244 neonates over 534 h. 54% of nursing shifts failed to meet BAPM standards. Nurses with workload greater than the BAPM-recommended levels demonstrated a 28% decrease in median time spent on clinical care per baby. 92 (17%) essential tasks were delayed &gt;1 h or not done. Delays/omissions were more likely when BAPM standards were not met (53% vs 40%, p=0.049). In nursing observations without delays/omissions, accommodating for adequate nursing breaks and working in the same area, nurses could cater for no more than 1.2, 1.5 and 2.7 babies in intensive care, high dependency care and special care, respectively.</p>
</sec>
<sec><st>Conclusion</st>
<p>Understaffing leads to measurable problems including delays to essential treatment and reduced clinical care. BAPM standards are not aspirational and should be regarded as a minimum. Further research on optimising nursing care efficiency with limited nursing resources is necessary.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Pillay, T., Nightingale, P., Owen, S., Kirby, D., Spencer, A.]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.300224</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.300224</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Nursing, Child health, Neonatal and paediatric intensive care, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Neonatal nurse staffing and delivery of clinical care in the SSBC Newborn Network]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F174</prism:startingPage>
<prism:endingPage>F178</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F179?rss=1">
<title><![CDATA[Workload and costs associated with providing a neonatal surgery service]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F179?rss=1</link>
<description><![CDATA[
<sec><st>Aim</st>
<p>To identify the workload related to provision of a neonatal surgical service in a UK neonatal network in order to inform local and national service commissioning.</p>
</sec>
<sec><st>Method</st>
<p>Data relating to neonatal surgical admissions to a level 3 perinatal centre serving a network with 36 000 births per year collected prospectively over a 5-year period were analysed to identify annual activity. Daily dependency was assessed prospectively over a 6-month period and service costs calculated using existing local tariffs. Admissions from outside the network were excluded from analysis, and allowance was made for refused network admissions.</p>
</sec>
<sec><st>Results</st>
<p>On average 140 admissions required 2137 cot-days per year. At 80% occupancy, the service requires seven neonatal cots suggesting that there is a national requirement for one neonatal surgical cot per 5000 births. Intensive care, high care (HC) and special care accounted for 37%, 46% and 17% of cot-days, respectively. This equates to an annual service cost of &pound;2m, about &pound;250 000 per 5000 births.</p>
</sec>
<sec><st>Conclusions</st>
<p>This assessment of the facilities and costs required to provide a neonatal surgical service in a level 3 perinatal centre in the UK may be used to inform network and national commissioning.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Burge, D. M., Drewett, M.]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300094</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300094</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Neonatal and paediatric intensive care, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Workload and costs associated with providing a neonatal surgery service]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F179</prism:startingPage>
<prism:endingPage>F181</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F182?rss=1">
<title><![CDATA[Multi-drug resistant gram negative bacilli causing early neonatal sepsis in India]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F182?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To study the organisms causing early and late onset neonatal sepsis, with special reference to multi-drug resistant gram negative bacilli, at two neonatal units (one urban, one rural) in India.</p>
</sec>
<sec><st>Methods</st>
<p>Prospective surveillance study.</p>
</sec>
<sec><st>Results</st>
<p>There were 159 episodes of sepsis (81 urban and 77 rural) affecting 158 babies. Gram negative bacilli caused 117 infections (68%) and predominated at both centres in both early and late sepsis. <I>Klebsiella pneumoniae</I> was the commonest organism, causing 61 infections (38.3%). In early sepsis (0&ndash;2 days), non-fermenting gram negative bacilli caused 42.1% of infections at the urban centre; there were no cases of early Group B Streptococcus sepsis. Late onset sepsis was mainly caused by gram negative bacilli at both centres. Multi-drug resistance of over 80% of early-onset gram negative organisms to ampicillin, third generation cephalosporins and gentamicin indicates that these multi-resistant organisms are almost certainly circulating widely in the community. The overall mortality from early sepsis was 27.3% (9 of 33) and from late sepsis was 26.2% (33 of 126). Gram negative bacilli caused all deaths from early sepsis and 87.5% of deaths from late sepsis.</p>
</sec>
<sec><st>Conclusion</st>
<p>This study shows that multi-drug resistant gram negative bacilli are a major cause of early and late neonatal sepsis in India and are almost certainly widespread in the community.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Viswanathan, R., Singh, A. K., Basu, S., Chatterjee, S., Sardar, S., Isaacs, D.]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300097</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300097</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Drugs: infectious diseases]]></dc:subject>
<dc:title><![CDATA[Multi-drug resistant gram negative bacilli causing early neonatal sepsis in India]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F182</prism:startingPage>
<prism:endingPage>F187</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F188?rss=1">
<title><![CDATA[Effective ventilation at conventional rates with tidal volume below instrumental dead space: a bench study]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F188?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>The authors previously showed that 48% of infants &lt;800 g were ventilated with tidal volume (VT) &lt; dead space (DS) using volume guarantee (VG) ventilation. Here, The authors sought to confirm those findings under the rigorous conditions of a bench study.</p>
</sec>
<sec><st>Design and methods</st>
<p>The authors measured the time to wash out CO2 from a 45-ml test lung using end-tidal CO<SUB>2</SUB> monitor (ETCO<SUB>2</SUB>). The test lung was filled with 100% CO<SUB>2</SUB>, then ventilated using VG at VT ranging from DS+2 ml to DS&ndash;1.5 ml. With ventilation, ETCO<SUB>2</SUB> declined exponentially as CO<SUB>2</SUB> was washed out, the rate being proportional to VT &ndash; effective instrumental DS. The time from initiation of ventilation to threshold of accurate detection was determined in triplicate.</p>
</sec>
<sec><st>Results</st>
<p>Halving the theoretical &lsquo;alveolar ventilation&rsquo; (DS+2 ml to DS+1 ml) only increased the elimination time by 26%, not the 100%, as predicted by conventional physiology. CO<SUB>2</SUB> washout was less efficient, but still occurred even at VT=DS and VT=DS&ndash;1.5 ml. Halving the theoretical &lsquo;alveolar ventilation&rsquo; by decreasing respiratory rate from 80 to 40 breaths/min only increased elimination time by 35%, not 100%, as predicted by conventional physiology. Twenty minutes of continuous positive airway pressure prior to ventilation did not alter the elimination time, verifying that CO<SUB>2</SUB> did not diffuse or leak out of the test lung. Size of the endotracheal tube (ETT; 2.5, 3.0 and 3.5 mm) flow rate (4, 6 and 10 l/min) and inspiratory time (0.25 vs 0.35 s) did not affect the results.</p>
</sec>
<sec><st>Conclusions</st>
<p>Contrary to conventional physiology, effective CO<SUB>2</SUB> elimination appears to be possible with VT&lt;DS even at conventional rates. With small ETT a spike of fresh gas likely penetrates through the DS, rather than pushing it ahead.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Keszler, M., Montaner, M. B., Abubakar, K.]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300647</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300647</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Effective ventilation at conventional rates with tidal volume below instrumental dead space: a bench study]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F188</prism:startingPage>
<prism:endingPage>F192</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F193?rss=1">
<title><![CDATA[Dopamine D2 receptor gene polymorphisms in newborn infants of drug-using women]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F193?rss=1</link>
<description><![CDATA[
<sec><st>Objectives</st>
<p>To determine the characteristics of dopamine D2 receptor gene (DRD2) polymorphisms in drug-exposed and unexposed neonates and the relationship to neonatal abstinence syndrome (NAS).</p>
</sec>
<sec><st>Design</st>
<p>Retrospective case-control analysis between drug-exposed and unexposed infants between DRD2 polymorphisms, drug exposure and NAS treatment.</p>
</sec>
<sec><st>Patients</st>
<p>Drug-exposed (n=48) and drug-free (n=49) infants born between March 1999 and December 2006.</p>
</sec>
<sec><st>Methods</st>
<p>Analysis of DNA for the Taq1A, -141Ins/Del and Ser311Cys DRD2 polymorphisms. Drug exposure was determined by antenatal maternal drug and alcohol history. Frequency measures of DRD2 polymorphisms were compared between drug-exposed infants, treatment NAS medication and with control infants.</p>
</sec>
<sec><st>Setting</st>
<p>Tertiary maternity hospital, Sydney, Australia.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>All infants were born in a good condition (25.7% &lt;37 weeks gestation). Opiates (methadone and heroin) were used by 45 (93.8%) of drug-exposed mothers. The A2A2 allele was more common in drug-exposed infants (37 (77.0%) versus 23 (46.9%), p=0.003) but the A1A2 allele was more common in control infants (23 (46.9%) versus 4 (8.3%), p=0.00002). The-ins allele was more common in control (39 (79.6%) versus 20 (41.7%), p=&lt;0.01) and unmedicated drug-exposed (14/25 (56%) versus 5/23 (21.7%), p=0.02) infants. The majority of infants (41 (83.7%) controls versus 41 (85.4%), p=1.000) expressed the least common, Ser polymorphism.</p>
</sec>
<sec><st>Conclusions</st>
<p>DRD2 polymorphisms are detectable from DNA obtained from stored blood spots. The &ndash;ins allele is more common in control and unmedicated drug-exposed infants. Further study is recommended to explore postneonatal outcomes especially in relation to neuropsychiatric behaviours.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Oei, J. L., Xu, H. X., Abdel-Latif, M. E., Vunnam, K., Al-Amry, A., Clews, S., Falconer, J., Feller, J. M., Lui, K.]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300235</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300235</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Molecular genetics, Drugs: CNS (not psychiatric)]]></dc:subject>
<dc:title><![CDATA[Dopamine D2 receptor gene polymorphisms in newborn infants of drug-using women]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F193</prism:startingPage>
<prism:endingPage>F198</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F199?rss=1">
<title><![CDATA[Fitness to fly testing in term and ex-preterm babies without bronchopulmonary dysplasia]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F199?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>During air flight, cabin pressurisation produces an effective fraction of inspired oxygen (FiO<SUB>2</SUB>) of 0.15. This can cause hypoxia in predisposed individuals, including infants with bronchopulmonary dysplasia (BPD), but the effect on ex-preterm babies without BPD was uncertain. The consequences of feeding a baby during the hypoxia challenge were also unknown.</p>
</sec>
<sec><st>Methods</st>
<p>Ex-preterm (without BPD) and term infants had fitness to fly tests (including a period of feeding) at 3 or 6 months corrected gestational age (CGA) in a body plethysmograph with an FiO<SUB>2</SUB> of 0.15 for 20 min. A &lsquo;failed&rsquo; test was defined as oxygen saturation (SpO<SUB>2</SUB>) &lt;90% for at least 2 min.</p>
</sec>
<sec><st>Results</st>
<p>41 term and 30 ex-preterm babies (mean gestational age 39.8 and 33.1 weeks, respectively) exhibited a significant median drop in SpO<SUB>2</SUB> (median &ndash;6%, p&lt;0.0001); there was no difference between term versus ex-preterm babies, or 3 versus 6 months. Two term (5%) and two ex-preterm (7%) babies failed the challenge. The SpO<SUB>2</SUB> dropped further during feeding (median &ndash;4% in term and &ndash;2% in ex-preterm, p&lt;0.0001), with transient desaturation (up to 30 s) &lt;90% seen in 8/36 (22%) term and 9/28 (32%) ex-preterm infants; the ex-preterm babies desaturated more quickly (median 1 vs 3 min, p=0.002).</p>
</sec>
<sec><st>Conclusions</st>
<p>Ex-preterm babies without BPD and who are at least 3 months CGA do not appear to be a particularly at-risk group for air travel, and routine preflight testing is not indicated. Feeding babies in an FiO<SUB>2</SUB> of 0.15 leads to a further fall in SpO<SUB>2</SUB>, which is significant but transient.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Bossley, C. J., Cramer, D., Mason, B., Hayward, A., Smyth, J., McKee, A., Biddulph, R., Ogundipe, E., Jaffe, A., Balfour-Lynn, I. M.]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.212001</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.212001</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Bronchopulmonary dysplasia]]></dc:subject>
<dc:title><![CDATA[Fitness to fly testing in term and ex-preterm babies without bronchopulmonary dysplasia]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F199</prism:startingPage>
<prism:endingPage>F203</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F204?rss=1">
<title><![CDATA[Neonatal resuscitation assessment: documentation and early paging must be improved!]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F204?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>The authors had previously found flaws in resuscitation after severe neonatal asphyxia in cases selected on the grounds of suspected malpractice and financial compensation claims. The aim of the present study was to evaluate neonatal resuscitation in the general obstetric population in a setting with skilled attendance at birth.</p>
</sec>
<sec><st>Design</st>
<p>Observational study.</p>
</sec>
<sec><st>Setting and patients</st>
<p>All infants born in the Stockholm County during 2004&ndash;2006 with a gestational age of &ge;33 weeks, planned as vaginal delivery, with a normal cardiotocographic recording on admission to hospital and with an Apgar score of &lt;7 at 5 min were included.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Adherence to guidelines for neonatal resuscitation.</p>
</sec>
<sec><st>Results</st>
<p>Documentation was unsatisfactory in 142 (45%) infants. Other important shortcomings identified were delayed initiation of extensive resuscitation due to late paging or late arrival of attending paediatrician/neonatologist (n=48), and unsatisfactory ventilation related to late intubation and late securing of free airway (n=15).</p>
</sec>
<sec><st>Conclusions</st>
<p>Substandard care in neonatal resuscitation is not limited to cases of severe asphyxia related to claims for medical malpractice. The overall documentation of neonatal resuscitation needs to be much better to enable accurate and reliable evaluation. Obvious actions to improve standards of care include the paging of skilled personnel at an earlier stage in cases of complicated deliveries and team and skills training in neonatal ventilation.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Berglund, S., Norman, M.]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300295</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300295</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Unlocked, Child health, Resuscitation, Trauma, Legal and forensic medicine, Injury]]></dc:subject>
<dc:title><![CDATA[Neonatal resuscitation assessment: documentation and early paging must be improved!]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F204</prism:startingPage>
<prism:endingPage>F208</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F209?rss=1">
<title><![CDATA[PHACES syndrome]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F209?rss=1</link>
<description><![CDATA[ <p>An infant of 31 weeks' gestation was noted at birth to have a scar-like lesion extending from the umbilicus to the xiphisternum (<cross-ref type="fig" refid="F1">figure 1</cross-ref>).</p> <p>An infantile haemangioma became apparent over her left face, extending into the mandibular area and lip, which gradually enlarged over the subsequent months (<cross-ref type="fig" refid="F2">figure 2</cross-ref>). At 3 years of age, the facial haemangioma has partially involuted.</p> <p>She developed respiratory distress and stridor at 3 weeks of age. Microlaryngo-bronchoscopy showed a subglottic haemangioma extending down the trachea circumferentially towards the carina requiring tracheostomy formation (<cross-ref type="fig" refid="F3">figure 3</cross-ref>). She was successfully decannulated at 3 years of age after involution of the haemangioma.</p> <p>Echocardiography and subsequent cardiac catheter study identified an aortic aneurysm (<cross-ref type="fig" refid="F4">figure 4</cross-ref>) requiring resection at 4 months of age.</p> <p>PHACES syndrome is an uncommon neurocutaneous syndrome that manifests with multisystem involvement. It refers to the association of posterior...]]></description>
<dc:creator><![CDATA[Mahadi, S., Malpas, T., O'Donnell, A., Roman, K., Jephson, C.]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300557</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300557</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Echocardiography, Radiology, Dermatology, Clinical diagnostic tests, Radiology (diagnostics), Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[PHACES syndrome]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F209</prism:startingPage>
<prism:endingPage>F210</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F211?rss=1">
<title><![CDATA[Congenital syphilis in Italy: a multicentre study]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F211?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To study the prevalence of congenital syphilis and its risk factors in Italy.</p>
</sec>
<sec><st>Study design</st>
<p>Prospective study from 1 July 2006 to 30 June 2007. Data on mother&ndash;child pairs were collected for every syphilis seropositive mother.</p>
</sec>
<sec><st>Results</st>
<p>Maternal syphilis seroprevalence at delivery was 0.17%. 207 infants were born to 203 syphilis seropositive mothers. In 25 newborns it was possible to diagnose congenital syphilis (20/100 000 live births). Maternal risk factors included age &lt;20 years, no antenatal care and no adequate treatment. The infected babies were more often preterm or weighed &lt;2000 g at birth.</p>
</sec>
<sec><st>Discussion</st>
<p>Many syphilis seropositive mothers were foreign born but the risk of an infected newborn was not higher in foreign-born than in Italian seropositive women. The significant factors were lack of antenatal screening and inadequate maternal treatment.</p>
</sec>
<sec><st>Conclusion</st>
<p>Syphilis is a re-emerging infection in Italy. Prevention strategies should include antenatal serological tests for all pregnant women and treatment for infected mothers.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Tridapalli, E., Capretti, M. G., Reggiani, M. L. B., Stronati, M., Faldella, G., The Italian Neonatal Task Force of Congenital Syphilis for The Italian Society of Neonatology - Collaborative Group]]></dc:creator>
<dc:date>2012-04-17T05:21:32-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.183863</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.183863</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Pregnancy, Reproductive medicine, Sexual health, Screening (epidemiology), Ethics of reproduction, Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Congenital syphilis in Italy: a multicentre study]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Short reports</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F211</prism:startingPage>
<prism:endingPage>F213</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F214?rss=1">
<title><![CDATA[Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F214?rss=1</link>
<description><![CDATA[
<p>It is widely accepted that maternal drug-exposed infants demonstrate excessive early weight loss, but this has not previously been quantified. Among 354 term, substitute methadone-exposed infants, median maximal weight losses were 10.2% and 8.5% for breast- and formula-fed infants, respectively (p=0.003). Weight loss was less in small for gestational age compared to appropriately grown infants (p&lt;0.001). There was no association between maximal weight loss and plasma sodium concentration (p=0.807). Relative to non-drug exposed infants, weight loss was more marked in formula-fed infants, 48% of whom demonstrated weight loss in excess of the 95th centile (compared to 23% of exclusively breastfed infants; p&lt;0.001). Median weight loss nadir was on day 5, excepting those infants exclusively breastfed (day 4). These data suggest that excessive neonatal weight loss among breastfed infants of drug-misusing mothers does not necessarily reflect poorly established lactation and may help to guide management of breast feeding in this population.</p>
]]></description>
<dc:creator><![CDATA[Dryden, C., Young, D., Campbell, N., Mactier, H.]]></dc:creator>
<dc:date>2012-04-17T05:21:33-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2009.178723</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2009.178723</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Childhood nutrition, Reproductive medicine, Infant nutrition (including breastfeeding)]]></dc:subject>
<dc:title><![CDATA[Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Short reports</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F214</prism:startingPage>
<prism:endingPage>F216</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F217?rss=1">
<title><![CDATA[Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F217?rss=1</link>
<description><![CDATA[ <p>Studies on probiotics for prevention of necrotising enterocolitis (NEC) show a risk reduction across all studies from 6.6% (165/2493) in the untreated to 2.5% (62/2433) in the treated patients.<cross-ref type="bib" refid="R1">1</cross-ref> However, modest limitations in all studies, for example, uncharacteristically high-baseline rate of NEC<cross-ref type="bib" refid="R2">2</cross-ref>- warrant cautious risk&ndash;benefit consideration. This ambivalence is reflected by the current European Society of Paediatric Gastroenterology, Hepatology and Nutrition guidelines,<cross-ref type="bib" refid="R3">3</cross-ref> not officially recommending their use whereas a recent cochrane review<cross-ref type="bib" refid="R4">4</cross-ref> suggests a change in practice.</p> <p>Monochorial-diamnial monocygotic twin pregnancy was diagnosed at 7 weeks gestational age (GA). Fetofetal transfusion syndrome was successfully treated with intrauterine laser ablation therapy at 16 weeks GA. At 27/5 weeks, caesarean section was performed due to premature rupture of membranes and uncontrollable labour. The index patient was born as the second twin weighing 600 g. Adaptation was uncomplicated; she received one dose of surfactant...]]></description>
<dc:creator><![CDATA[Jenke, A., Ruf, E.-M., Hoppe, T., Heldmann, M., Wirth, S.]]></dc:creator>
<dc:date>2012-04-17T05:21:33-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300838</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300838</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Oncology, Journalology, Immunology (including allergy), Drugs: infectious diseases, Childhood nutrition, Pregnancy, Reproductive medicine, Childhood nutrition (paediatrics), Child health, Infant health, Infant nutrition (including breastfeeding), Neonatal health, Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Case reports</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F217</prism:startingPage>
<prism:endingPage>F218</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F219?rss=1">
<title><![CDATA[Designing the new UK-WHO growth charts to enhance assessment of growth around birth]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F219?rss=1</link>
<description><![CDATA[
<p>The decision to adopt the new WHO standard in the UK necessitated substantial changes to the neonatal section of the chart, including separation of the preterm UK birth weight reference from the WHO standard. The evidence-based design process has led to several novel features that could be generally applied in other chart designs, and revealed uncertainties leading to inconsistencies in charting. Failing to plot the birth weight of term infants at age 0 can lead to spurious centile crossing in the early weeks of life, particularly among infants at the extreme of gestation. Users will need training to use the charts, but this should improve overall understanding and the use of charts.</p>
]]></description>
<dc:creator><![CDATA[Cole, T. J., Wright, C. M., Williams, A. F., RCPCH Growth Chart Expert Group]]></dc:creator>
<dc:date>2012-04-17T05:21:33-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.205864</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.205864</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Designing the new UK-WHO growth charts to enhance assessment of growth around birth]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Reviews</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F219</prism:startingPage>
<prism:endingPage>F222</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F223?rss=1">
<title><![CDATA[The management of neonatal pulmonary hypertension]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F223?rss=1</link>
<description><![CDATA[
<p>Most neonates with clinically significant pulmonary hypertension (PH) will have either persistent PH of the newborn (PPHN) or bronchopulmonary dysplasia. Cyanotic congenital heart disease must be actively ruled out as part of the differential diagnosis of PPHN. The maintenance of ductal patency with prostaglandins E1 or E2 in cases of doubt is safe and potentially beneficial given their pulmonary vasorelaxant properties. Specific tools in the treatment of PPHN include modern ventilatory strategies, inhaled nitric oxide, sildenafil, prostacyclin and extracorporeal membrane oxygenation.</p>
<p>Rarely will a cardiac lesion be primarily responsible for neonatal PH although pulmonary vein stenosis and the persistence of an arterial duct must be considered, particularly in the older preterm baby with bronchopulmonary dysplasia.</p>
]]></description>
<dc:creator><![CDATA[Dhillon, R.]]></dc:creator>
<dc:date>2012-04-17T05:21:33-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2009.180091</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2009.180091</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[The management of neonatal pulmonary hypertension]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Reviews</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F223</prism:startingPage>
<prism:endingPage>F228</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F229?rss=1">
<title><![CDATA[Management of posthaemorrhagic ventricular dilatation]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F229?rss=1</link>
<description><![CDATA[
<p>Intraventricular haemorrhage and posthaemorrhagic ventricular dilatation remain an important challenge in the management of prematurity and are associated with significant permanent morbidity. Progressive ventricular dilatation causes white matter injury by pressure, distortion, free radical injury and inflammation. Therapeutic interventions include serial lumbar punctures, only useful when the ventricles remain in communication with the lumbar subarachnoid space, and repeated aspiration through a ventricular access device. Reduction of cerebrospinal fluid production by acetazolamide and frusemide in a large multicentre randomised trial showed a worse outcome in the treated arm. A trial of drainage, irrigation and fibrinolytic therapy did not demonstrate a reduced need for permanent cerebrospinal fluid diversion, but did show a significant reduction in severe cognitive disability at two years. Ventriculoperitoneal shunting is indicated when the ventricles continue to enlarge at a body weight of around 2.5 kg and cerebrospinal fluid protein levels are below 1.5 g /L.</p>
<p>This review summarises current concepts on the pathophysiology and management of posthaemorrhagic ventricular dilatation, underlining clinical challenges and ongoing research.</p>
<p>Although the percentage of small preterm infants developing intraventricular haemorrhage (IVH) has been greatly reduced in the last three decades, increased survival of very immature infants has meant that large IVH with subsequent posthaemorrhagic ventricular dilatation is still a serious unsolved problem.</p>
]]></description>
<dc:creator><![CDATA[Whitelaw, A., Aquilina, K.]]></dc:creator>
<dc:date>2012-04-17T05:21:33-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.190173</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.190173</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Management of posthaemorrhagic ventricular dilatation]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Reviews</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F229</prism:startingPage>
<prism:endingPage>F233</prism:endingPage>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/97/3/F234?rss=1">
<title><![CDATA[Strategies to manage resistant gram-negative organisms in neonates]]></title>
<link>http://fn.bmj.com/cgi/content/short/97/3/F234?rss=1</link>
<description><![CDATA[ <p>Gram-negative antibiotic resistance is currently of major concern worldwide. In the UK, the prevalence of multi-resistant gram-negative bacteria (MRGNB) is increasing,<cross-ref type="bib" refid="R1">1</cross-ref> and outbreaks have occurred in neonatal units (NNUs).</p> <p>Up to 12% of neonates undergo a septic screen at birth, and most of them receive empiric antibiotics.<cross-ref type="bib" refid="R2">2</cross-ref> Around 70% of NNUs use narrow-spectrum penicillin/gentamicin combinations for empiric treatment of neonatal sepsis.<cross-ref type="bib" refid="R3">3</cross-ref> However, these regimens may not be active against MRGNB. Vergnano <I>et al</I><cross-ref type="bib" refid="R4">4</cross-ref> found that <I>Enterobacteriaceae</I> accounted for around 20% to 35% of early- and late-onset sepsis, respectively, underlining the threat that MRGNB pose in neonatology. Unlike many other antibiotic-resistant bacteria, MRGNB occur in the community as well as in hospitals, meaning that there is a growing risk of mother-to-baby transmission of MRGNB. This could lead to infected babies being inadequately treated with standard antibiotics, and asymptomatically colonised babies could act...]]></description>
<dc:creator><![CDATA[Wickramasinghe, N., Suviste, J., Patel, M., Gray, J.]]></dc:creator>
<dc:date>2012-04-17T05:21:33-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301480</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301480</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Strategies to manage resistant gram-negative organisms in neonates]]></dc:title>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>PostScript</prism:section>
<prism:volume>97</prism:volume>
<prism:number>3</prism:number>
<prism:startingPage>F234</prism:startingPage>
<prism:endingPage>F234</prism:endingPage>
</item>
</rdf:RDF>
